Robins Jason Shand — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Robins Jason Shand has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Jason Shand Robins is listed as the Interim Chief Financial Officer of Ocular Therapeutix, Inc. (OCUL) in SEC filings with the most recent filing dated January 22, 2026. In that filing, there are no reported purchases or sales by him and he is noted in connection with OCUL's executive leadership, indicating a financial oversight role during a corporate transition.

Board memberships

• Ocular Therapeutix, Inc. (OCUL)

Awards & honors

• Holding an interim CFO role at OCUL during a leadership transition
• Overseeing financial operations as part of OCUL's executive team

Recent Transactions

Companies — Last 90 Days

• OCULAR THERAPEUTIX, INC (OCUL) — 1 filings, last 2026-06-12

Frequently Asked Questions

Who is Robins Jason Shand?

Jason Shand Robins is listed as the Interim Chief Financial Officer of Ocular Therapeutix, Inc. (OCUL) in SEC filings with the most recent filing dated January 22, 2026. In that filing, there are no reported purchases or sales by him and he is noted in connection with OCUL's executive leadership, indicating a financial oversight role during a corporate transition.…

How many SEC Form 4 filings has Robins Jason Shand submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Robins Jason Shand's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week